HCAVSSXTC• 3 Months (Normalized)
HCA vs SXTC (HCA Healthcare Inc. vs China SXT Pharmaceuticals Inc.)
Showing Closing Date Range from Jul 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
HCA Performance $426.69
+2.31%
HCA Healthcare Inc.
Normalized Baseline0.00%
SXTC Performance $2.41
-98.74%
China SXT Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin HCA LEADS
+101.05 pts
HCA outperforming by 101.05 percentage points
HCASXTC
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
HCA SXTC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(64 dates)
| Date | HCA Price | HCA Gain (%) | SXTC Price | SXTC Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $426.69 | +2.31% | $2.41 | -98.74% | +101.05% |
| Oct 01, 2026 | $- | $2.96 | -98.45% | - | |
| Sep 30, 2026 | $430.43 | +3.20% | $3.01 | -98.43% | +101.63% |
| Sep 29, 2026 | $431.63 | +3.49% | $2.81 | -98.53% | +102.02% |
| Sep 28, 2026 | $432.60 | +3.72% | $2.52 | -98.68% | +102.40% |
| Sep 25, 2026 | $435.61 | +4.45% | $- | - | |
| Sep 24, 2026 | $423.48 | +1.54% | $- | - | |
| Sep 23, 2026 | $436.48 | +4.65% | $2.51 | -98.69% | +103.34% |
| Sep 22, 2026 | $438.12 | +5.05% | $- | - | |
| Sep 21, 2026 | $425.97 | +2.13% | $2.38 | -98.76% | +100.89% |
| Sep 18, 2026 | $427.71 | +2.55% | $2.40 | -98.74% | +101.29% |
| Sep 17, 2026 | $429.04 | +2.87% | $2.44 | -98.73% | +101.60% |
| Sep 16, 2026 | $430.43 | +3.20% | $2.19 | -98.85% | +102.05% |
| Sep 15, 2026 | $423.82 | +1.62% | $2.36 | -98.77% | +100.39% |
| Sep 14, 2026 | $425.49 | +2.02% | $2.66 | -98.61% | +100.63% |
Page 1 of 5